This legislation has been repealed.
[This Regulation commenced on 01 July 2012 and was repealed by the MEDICINES, POISONS AND THERAPEUTIC GOODS ACT 2012, NO. 13 which commenced on the 01 May 2014.]
NORTHERN TERRITORY OF
AUSTRALIA
POISONS AND DANGEROUS DRUGS
REGULATIONS
As in force at 11 December 2001
TABLE OF PROVISIONS
Regulation
PART I - PRELIMINARY
1. Citation
2. Commencement
3. Interpretation
PART II - LABELLING - GENERAL
4. Writing on label, &c.
5. Dangerous poison, poison, caution or warning, etc.
6. References, statements, &c., on label prohibited
7. Label not to obscure writing on immediate container or primary pack
8. Labelling of immediate wrapper
9. Labelling of immediate container and primary pack
10. Veterinary products
11. Pesticides
12. These regulations not to apply in certain cases
13. Statement of strength of preparations
14. Selected containers
15. Containers
16. Offences
SCHEDULE 1
SCHEDULE 2
SCHEDULE 3
SCHEDULE 4
SCHEDULE 5
SCHEDULE 6
Notes
Table of Amendments
NORTHERN TERRITORY OF AUSTRALIA
____________________
This reprint shows the Regulations as in force at 11 December 2001. Any amendments that may come into operation after that date are not included.
____________________
POISONS AND DANGEROUS DRUGS REGULATIONS
Regulations under the Poisons and Dangerous Drugs Act
PART I - PRELIMINARY
These Regulations may be cited as the Poisons and Dangerous Drugs Regulations. (See back note 1)
These Regulations shall come into operation at the expiration of 14 days from the date on which the making of the Regulations is notified in the Gazette. (See back note 1)
(1) In these Regulations, unless the contrary intention appears -
"approved" means approved by the Chief Health Officer;
"immediate container" includes any form of container, in which a poison or hazardous substance, in any condition or state, is directly packed, but does not include a container intended for consumption or an immediate wrapper;
"immediate wrapper" means tin foil, plastic foil, waxed paper, or other similar material not intended for human or animal consumption, when used as the first wrapper covering a tablet, capsule, pastille, dose of powder or other discrete product unit which contains a poison or hazardous substance;
"internal use", in relation to a substance, means the administration orally, parenterally or by way of a body orifice for the purpose of absorption and the production of a systemic effect;
"label" includes all labels, brands, marks or state-ments in writing whether or not containing any pictorial or other descriptive matter, on or attached to (except as a removable tag), or used in connection with a container or outer cover containing a poison or hazardous substance;
"main label" means that portion of the label where the name of the product is most prominently shown, but where the name of the product is equally prominent on 2 or more portions, each shall be considered to be a main label;
"measure pack" means a package which contains a quantity of pesticide ready for dilution and of which 2 or more are contained in a larger fully labelled package;
"poison" means a substance specified in Schedule II or III of Part A, or Schedule 1, 2, 3, 4, 6, 7 or 8 of Part B, of the Act;
"primary pack" means the complete pack in addition to the immediate container as presented to the purchaser in a single retail sale and may include measure packs, excluding any wrapping, bag, carton or similar article in which an immediate container is placed at the time of sale;
"selected container" means -
(a) an injection vial having a capacity of 10 mL or less;
(b) a single use syringe; or
(c) a container for substances for therapeutic use having a capacity of 10 mL or less;
"withholding period", in relation to an agricultural chemical or veterinary drug, is the period declared under subregulation (2) by the Chief Health Officer, which must be allowed to elapse between the last application of the agricultural chemical or veterinary drug and the harvest of plant products, grazing of treated pastures, slaughter of treated animals, or offering for sale of any product or produce such as milk derived from treated animals.
(2) For the purposes of these Regulations, the Chief Health Officer may, by notice in the Gazette, declare a withholding period.
PART II - LABELLING - GENERAL
(1) Every word, expression and statement required to be written on a label or container used in connection with a poison or hazardous substance shall be written -
(a) in the English language;
(b) on the outside face of the label or container;
(c) in durable characters; and
(d) in such colour or colours as to afford a distinct contrast to the background colour.
(2) Every label, used in connection with a poison or hazardous substance, shall be securely attached to the outside of the container or pack in which the poison or hazardous substance is packed.
(3) Where a specific direction or authorization is not otherwise given in these Regulations as to the manner in which an expression or particular shall be written on a label, the expression or particular shall be written in bold face sans serif capital letters -
(a) of which no letter shall be less than 1.5 mm in height;
(b) the ratio between the thickness and the height of which shall be not less than the representations specified in Schedule 1; and
(c) which shall be in accordance with subregulation (1).
(1) The word "DANGEROUS POISON", "POISON", "CAUTION" or "WARNING", as the case may be, together with the classification symbol, if any, specified in Column 1 of Schedule 2 and in regulation 9(3), shall be written in capital letters -
(a) in red on a white background;
(b) on the first line of the main label;
(c) in bold sans serif capital letters; and
(d) in accordance with regulation 4(1).
(2) The word and symbol referred to in subregulation (1) shall be separated by means of a rectangular red border surrounding the word and the rectangular red border shall be placed at a discrete distance from the symbol.
(3) The word "DANGEROUS POISON", "POISON" or "CAUTION", as the case may be, referred to in subregulation (1) shall be written in capital letters on the main label in letters with a size of -
(a) not less than 1.5 mm; and
(b) not less than 0.5 of the size in height of the largest letter or numeral on the main label.
(4) The word "WARNING" referred to in subregulation (1) shall be written in capital letters on the main label in letters with a size of -
(a) not less than 4.5 mm; and
(b) not less than 0.25 of the size in height of the largest letter or numeral on the main label.
(5) Where the phrase -
(a) "NOT TO BE TAKEN";
(b) "USE STRICTLY AS DIRECTED";
(c) "SUPPLY WITHOUT PRESCRIPTION OR POSSESSION WITHOUT AUTHORITY ILLEGAL":
(d) "SUPPLY WITHOUT PRESCRIPTION ILLEGAL"; or
(e) "UNAUTHORIZED SUPPLY ILLEGAL",
is required to be written on a label, the phrase shall be written on the main label -
(i) on the next line or lines immediately below the word "POISON" or the word "CAUTION", as the case may be;
(ii) in bold sans serif capital letters; and
(iii) in accordance with regulation 4(1);
(6) The words "KEEP OUT OF REACH OF CHILDREN" shall be written on a main label -
(a) in red;
(b) on the next line immediately below the word "WARNING" or the relevant phrase referred to in subregulation (5)(a) to (e) inclusive;
(c) in bold sans serif capital letters; and
(d) in accordance with regulation 4(1).
(7) In the case of a substance specified in Schedule 5 of the Act, the words "KEEP OUT OF REACH OF CHILDREN" shall be written in capital letters on the main label in letters not less than 0.5 the size in height of the letters used to write the word "WARNING".
(8) Where the phrase "READ SAFETY DIRECTIONS BEFORE OPENING" is required to be written on the label, the phrase shall be written on the main label -
(a) on the line or lines immediately below the words "KEEP OUT OF REACH OF CHILDREN";
(b) in bold sans serif capital letters; and
(c) in accordance with regulation 4(1).
(9) No word, other than the word or phrase referred to in subregulations (1), (5), (6), (7) and (8), shall be written on the same line as a word or phrase required by those subregulations.
A label used in connection with a poison or hazardous substance shall not include -
(a) a reference to these Regulations, or any comment on, reference to, or explanation of any expression required by these Regulations which directly or by implication contradicts, qualifies or modifies such expression;
(b) a statement suggesting or implying that such poison or hazardous substance has been recom-mended or approved by the Commonwealth or the Territory;
(c) a statement implying that the poison or hazardous substance is safe, harmless, non-toxic, non-poisonous or approved;
(d) an expression or device which is false or misleading in a particular concerning the safety of the poison or hazardous substance or any of its ingredients; or
(e) a trade name which is false or misleading in a particular concerning the poison or hazardous substance or the ingredients or substances contained therein or which misrepresents the composition or a property or quality of the poison or hazardous substance or which gives a false or misleading indication of origin or place of manufacture.
A label shall not be affixed or attached to an immediate container or primary pack, in which a poison or hazardous substance is packed, in such a manner as to obscure -
(a) a word or phrase required by these Regulations to be written on the immediate container or primary pack; or
(b) any of the embossed points, ridges, flutes or stars required by these Regulations to be written on the immediate container or primary pack.
A person shall not supply a poison or hazardous substance contained in an immediate wrapper unless the immediate wrapper is contained in a primary pack which is labelled in accordance with these Regulations, and that immediate wrapper is labelled conspicuously with -
(a) the registered brand or the name of the manufacturer;
(b) the name of the poison or hazardous substance appearing in a Schedule to the Act or these Regulations;
(c) a statement, in accordance with regulation 13 as to the strength of the preparation; and
(d) the labelling specified in Column 2 of Schedule 3 in accordance with the use specified in Column 1 of that Schedule opposite the labelling so specified.
(1) The immediate container and primary pack containing a poison or hazardous substance for sale shall be labelled with -
(a) the particulars relating to the class of poison or hazardous substance specified in Column 1 of Schedule 2 in accordance with the use specified in Column 2 of that Schedule opposite the particulars so specified;
(b) subject to subregulation (2), the name of each poison or hazardous substance appearing in a Schedule to the Act or these Regulations and a statement of the quantity of the poison or hazardous substance or the proportion which the poison or hazardous substance bears to the total ingredients of the preparation;
(c) directions for use if the poison, not being a substance in Schedule 4 or 8 of the Act, or hazardous substance is made up for a specific purpose;
(d) the name and address of the manufacturer or distributor;
(e) if the substance is specified in Column 1 of Part B of Schedule 5, the directions specified for safe handling and, unless variations of the special warnings have been approved by the Chief Health Officer, special warnings in Part A of that Schedule and in accordance with the directions referring to Part A by means of the numerations specified in Column 2 of Part B opposite the substance so specified;
(f) if the substance is specified in Column 1 of Part C of Schedule 6, unless variations of the first aid instructions have been approved by the Chief Health Officer, the first aid instructions specified in Part A of that Schedule and in accordance with the first aid instructions referring to Part A by means of the lettering specified in Column 2 of Part C opposite the substance so specified, provided it is in accordance with the guide specified in Part B of that Schedule; and
(g) if applicable, the withholding period.
(2) In the case of a preparation containing more than one derivative of the same substance as with the alkaloids of aconite or the arsenical poisons, it shall be sufficient to state the equivalent proportion of one derivative that the preparation would be calculated to contain on the assumption that all the derivatives in the preparation were that derivative.
(3) The particulars specified in -
(a) Column 1 of Schedule 2 shall be written on the label in accordance with regulation 5; and
(b) subregulation (1)(b),
shall appear on the main label of an immediate container or primary pack containing a poison or hazardous substance.
(4) These Regulations do not apply to or in relation to an immediate container and primary pack containing a poison or hazardous substance for bulk distribution or further processing if the immediate container or primary pack is labelled with -
(a) the word "POISON", "DANGEROUS POISON", "CAUTION" or "WARNING", as the case may be;
(b) the name of the poison or hazardous substance appearing in a Schedule to the Act or these Regulations; and
(c) the registered brand or the name of the manu-facturer or distributor.
The immediate container and the primary pack in which a poison or hazardous substance is packed and prepared for the treatment of animals only shall be labelled with the words "FOR ANIMAL TREATMENT ONLY" written in bold sans serif capital letters with a letter size of not less than 2.5 mm and in accordance with regulation 4(1).
(1) The immediate container and the primary pack in which a poison or hazardous substance is packed and prepared for use as a pesticide shall be labelled with -
(a) the words "NOT TO BE USED FOR ANY OTHER PURPOSE OR IN ANY MANNER, CONTRARY TO THIS LABEL UNLESS AUTHORIZED UNDER APPROPRIATE LEGISLATION" written in bold sans serif capital letters with a letter size of not less than 2.5 mm and in accordance with regulation 4(1); and
(b) the withholding period (where applicable) in bold sans serif capital letters and in accordance with regulation 4(1).
(2) The words and withholding period referred to in subregulation (1)(a) and (b) respectively shall be written on a separate line or lines of the label.
(3) Measure packs to be used in connection with pesticides shall be labelled in accordance with regulation 14(3)(a), (b) and (c).
These Regulations do not apply to a label which may be otherwise required by these
Regulations -
(a) where a poison or hazardous substance is dispensed on prescription by a registered pharmacist under the Pharmacy Act and the name of the poison or hazardous substance is written on the label by the registered pharmacist; or
(b) to be placed on a packing case, crate, hamper, transparent cover, wrapper or other cover used solely for the purposes of transport and delivery.
(1) A statement of the quantity of a poison or hazardous substance or the proportion which the poison or hazardous substance bears to the total ingredients of a preparation required to be written on a label in accordance with regulation 8(c) or 9(1)(b) shall be -
(a) in the case of -
(i) a tablet, capsule, pastille, packaged single dose of powder, or similar discrete product unit - the quantity of each poison or hazardous substance in the product unit;
(ii) a solid preparation intended for extemporaneous preparation of either a single dose or a single stated amount of a liquid for therapeutic use - the quantity of each poison or hazardous substance in the immediate container; or
(iii) a liquid for internal therapeutic use - the volume of the normal dose and the quantity of each poison or hazardous substance in that volume; and
(b) in the case of any other preparation -
(i) liquid poison or hazardous substance in a liquid preparation - the mass or volume of the poison or hazardous substance per stated volume of the preparation;
(ii) liquid poison or hazardous substance in a solid or semi-solid preparation - the mass or volume of the poison or hazardous substance per stated mass of the preparation;
(iii) solid or semi-solid poison or hazardous substance in a liquid preparation - the mass of the poison or hazardous substance per stated volume of the preparation;
(iv) solid or semi-solid poison or hazardous substance in a solid or semi-solid preparation - the mass of the poison or hazardous substance per stated mass of the preparation;
(v) gaseous poison or hazardous substance in a liquid preparation - the mass of the poison or hazardous substance per stated volume of the preparation;
(vi) gaseous poison or hazardous substance in a solid or semi-solid preparation - the mass of the poison or hazardous substance per stated mass of the preparation; or
(vii) gaseous poison or hazardous substance in a gaseous preparation - the mass of the poison or hazardous substance per stated mass of the preparation.
(2) Where in the Schedules to the Act or these Regulations a poison or hazardous substance is expressed in grams per litre or multiples of grams per litre or grams per kilogram or multiples of grams per kilogram, it shall mean -
(a) in the case of a liquid preparation - a preparation containing the poison or hazardous substance in the proportion of one gram of that poison or hazardous substance per litre of the preparation; or
(b) in the case of any other preparation - a preparation containing the poison or hazardous substance in the proportion of one gram of that poison or hazardous substance per kilogram of the preparation.
(3) Where in the Schedules to the Act or these Regulations the abbreviation "1%" is used in relation to a poison or hazardous substance, it means -
(a) in the case of a liquid preparation - a preparation containing that poison or hazardous substance in the proportion of 1 g of the poison or hazardous substance for 100 mL of the preparation; and
(b) in the case of any other preparation - a preparation containing that poison or hazardous substance in the proportion of 1 g of the poison or hazardous substance for 100 g of preparation, except where -
(i) the abbreviation "%" is followed by the abbreviation "(w/v)" in which case the meaning in paragraph (a) shall apply;
(ii) the abbreviation "%" is followed by the abbreviation "(w/w)" in which case the meaning in paragraph (b) shall apply; and
(iii) the abbreviation "%" is followed by the abbreviation "(v/v)" in which case it means a preparation containing that poison or hazardous substance in the proportion of 1 mL of the poison or hazardous substance per 100 mL of the preparation,
and abbreviations for greater or lesser quantities shall have a corresponding meaning.
(1) A selected container containing a poison or hazardous substance shall be labelled in accordance with regulation 9 and, if applicable, regulation 10.
(2) Where a selected container is not labelled in accordance with regulation 9 and, if applicable, regulation 10, it shall not be supplied except in a primary pack.
(3) A primary pack containing a selected container shall be labelled in accordance with regulations 9 and 10 and also be labelled with -
(a) the particulars relating to the class of poison or hazardous substance specified in Column 2 of Schedule 3 in accordance with the use specified in Column 1 of that Schedule opposite the particulars so specified;
(b) the name of the poison or hazardous substance appearing in a Schedule to the Act or these Regulations and the strength of the preparation;
(c) the registered brand or the name of the manufacturer or distributor; and
(d) if the preparation is for treatment of animals only, the words "FOR ANIMAL TREATMENT ONLY" written in accordance with regulation 10.
(1) The immediate container in which a poison or hazardous substance is supplied shall be -
(a) impervious to such poison or hazardous substance; and
(b) sufficiently strong to prevent leakage arising from the ordinary risks of handling, storage or transport.
(2) Every bottle, can, drum, jar, tube or like type of immediate container in which a poison or hazardous substance is sold shall be securely closed and shall, except when containing preparations packed for use on one occasion only, be capable of being reclosed.
(3) The immediate container in which a poison or hazardous substance is sold shall have sufficient excess capacity to prevent breakage of the container or leakage of the contents if the contents are likely to expand during handling, storage or transport.
(4) A poison shall not be sold in a bottle or jar having a capacity of 2 litres or less unless -
(a) the outer surface of such bottle or jar has embossed thereon the word "poison" or the words "not to be taken";
(b) the outer surface of such bottle or jar has embossed thereon prominent vertical ribs or grooves or prominent points or stars of sufficient number to render the bottle or jar distinguishable by sight and by touch from bottles or jars ordinarily used as containers for any food, drink or condiment or for medicine for internal use;
(c) the outer surface of such bottle or jar has a panel or panels free from ribs, grooves, points or stars of sufficient area for the purpose of labelling;
(d) such bottle or jar is colourless or coloured brown if made of glass; and
(e) such bottle or jar if made of plastic complies with the Australian Standard Specification for Plastic Containers for Poisonous Substances as published by the Standards Association of Australia.
(5) A poison shall not be sold in a bottle or jar having a capacity of more than 2 litres or in any other immediate container unless -
(a) the word "poison" is embossed on the side or shoulder of such bottle or jar or other immediate container; or
(b) the word "POISON" is written in capital letters indelibly on the side or shoulder of such bottle or jar or other immediate container in distinct contrast to the background in letters of a height not less than 0.032 part of the depth, height or width, whichever is the greater, of the bottle or jar or other immediate container.
(6) A hazardous substance shall not be sold unless the container thereof is readily distinguishable from a container in which food, wine or other beverage is sold and has embossed or indelibly written thereon the words "Not to be used as a food container" or the words "Not to be taken".
(7) Notwithstanding subregulation (6), a poison or hazardous substance, specified in Column 1 of Schedule 4, and contained in a bottle, can or jar of the capacity specified in Column 2 opposite the poison or hazardous substance so specified shall not be supplied unless it is -
(a) closed with a closure specified in Column 3 of Schedule 4 opposite the capacity so specified; and
(b) complies with the requirements of subregulations (4) and (5).
(8) An immediate container having the name of a poison or hazardous substance written thereon shall not be used except for the purpose of putting therein a poison or hazardous substance corresponding to the name so written.
(9) A poison or hazardous substance shall not be sold in any type of immediate container which is capable of causing a chemical reaction with such poison or hazardous substance.
(10) The requirements of subregulations 1 to 9 inclusive in respect of containers shall not apply to -
(a) the immediate container of a poison or hazardous substance made up ready -
(i) for internal human or internal animal use; or
(ii) for use as eye, ear or nose drops or sprays when placed in a container containing 15 mL or less of medicament unless the poison or hazardous substance is specified in Column 1 of Schedule 4; or
(b) the immediate container of a poison or hazardous substance for use in automatic photographic and photocopying processing machines where the container is specifically designed to fit into the machine.
(11) Notwithstanding subregulations (1) to (10) inclusive, bottles for eyedrops containing poisons or hazardous substances -
(a) shall be capable of being sterilized;
(b) shall have a locking cap with a screw or bayonet type fitting capable of delivering drops;
(c) need not be of a particular colour; and
(d) shall be distinguishable by touch by fluting, ribbing or stars, except bottles of 15 mL or less in capacity.
(12) A person shall not sell a drug or medicine which is for internal use or any food, drink or condiment in a container of -
(a) like description to that prescribed for a container in which a poison or hazardous substance intended for external use may be sold; or
(b) such a description as not to be readily distinguishable by sight and touch from a container in which such a poison or hazardous substance may be sold.
Any person who -
(a) sells a poison or hazardous substance contrary to the provisions of these Regulations; or
(b) neglects or omits to comply with a provision of these Regulations,
shall be guilty of an offence.
Penalty: $2,000.
____________________________
SCHEDULE 1
Regulation 4(3)(b)
____________________________
SCHEDULE 2
Regulation 5(1) and 9(1)(a) and (3)(a)
|
Column 1
Labelling required
|
Column 2
(Use)
|
1.
|
POISON S1
USE STRICTLY AS DIRECTED
KEEP OUT OF REACH OF CHILDREN
POISON S1
NOT TO BE TAKEN
KEEP OUT OF REACH OF CHILDREN
|
When made up for internal use
When made up for any other
purposes
|
2.
|
CAUTION S2
USE STRICTLY AS DIRECTED
KEEP OUT OF REACH OF CHILDREN
POISON S2
NOT TO BE TAKEN
KEEP OUT OF REACH OF CHILDREN
|
For internal use and for topical oral
use
For any purpose other than internal use or
topical oral use
|
3.
|
CAUTION S3
USE STRICTLY AS DIRECTED
KEEP OUT OF REACH OF CHILDREN
POISON S3
NOT TO BE TAKEN
KEEP OUT OF REACH OF CHILDREN
|
For internal use and for topical oral
use
For any purpose other than internal use or
topical oral use
|
4.
|
CAUTION S4
SUPPLY WITHOUT PRESCRIPTION ILLEGAL KEEP OUT
OF REACH OF CHILDREN
|
|
5.
|
WARNING KEEP OUT OF REACH OF
CHILDREN
|
|
6.
|
CAUTION
USE STRICTLY AS DIRECTED
KEEP OUT OF REACH OF CHILDREN
|
Preparations for internal use in animals
except those administered by dermal application
|
|
POISON
NOT TO BE TAKEN
KEEP OUT OF REACH OF CHILDREN
READ SAFETY DIRECTIONS BEFORE
OPENING
|
Preparations for other purposes including
those which are for internal use but which are administered by dermal
application
|
7.
|
CAUTION S7
UNAUTHORIZED SUPPLY ILLEGAL
KEEP OUT OF REACH OF CHILDREN
|
Preparations for internal use except those
administered by dermal application
|
|
DANGEROUS POISON S7
NOT TO BE TAKEN
KEEP OUT OF REACH OF CHILDREN
READ SAFETY DIRECTIONS BEFORE
OPENING
|
Preparations for other purposes including
those which are for internal use but which are administered by dermal
application
|
8.
|
CAUTION S8
SUPPLY WITHOUT PRESCRIPTION OR POSSESSION
WITHOUT AUTHORITY ILLEGAL KEEP OUT OF REACH OF CHILDREN
|
|
____________________________
SCHEDULE 3
Regulation 8(d)
|
Column 1
(Use)
|
Column
2
(Labelling required) |
1
|
|
POISON
|
2
|
(if for internal use)
|
CAUTION
|
2
|
(if for any purpose other than internal
use)
|
POISON
|
3
|
|
CAUTION
|
4
|
|
CAUTION
|
5
|
|
WARNING
|
6
|
(if for any purpose other than internal
use)
|
POISON
|
6
|
(if for internal use)
|
CAUTION
|
7
|
(if for any purpose other than internal
use)
|
DANGEROUS POISON
|
7
|
(if for internal use)
|
CAUTION
|
8
|
|
CAUTION
|
____________________________
SCHEDULE 4
Regulation 15(7)(a)
Column 1
(substance)
|
Column 2
(capacity)
|
Column
3
(closure) |
Hydrocarbons liquid, including kerosene,
mineral turpentine, oil of turpentine and white petroleum spirit which have been
distilled at a temperature less than 300°C, but excluding their dervatives,
and except in -
(a) a solid or semi solid cleaning and
polishing preparation;
(b) a preparation containing 25% or less of a
total of liquid hydrocarbons;
(c) a preparation packed in an aerosol
container; or
(d) an adhesive packed in a container
containing 50 grams or less of adhesive.
|
5 litres or less
|
Approved child-resistant
|
Methylated spirit
|
5 litres or less
|
Approved child-resistant
|
Hydrochloric acid in aqueous preparations
when included in Schedule 6 of the Act
|
2.5 litres and less
|
Approved child-resistant
|
Sodium hydroxide (except in aerosols) in oven
or drain cleaners when included in Schedule 6 of the Act
|
any capacity
|
Approved child-resistant
|
Sodium hydroxide as such in bottles, cans or
jars with screw threads
|
2.5 litres or less
|
Approved child-resistant
|
Sodium hydroxide as such in cans with
press-in lids
|
2.5 litres or less
|
Approved double-tight
|
____________________________
SCHEDULE 5
Regulation 9(1)(e)
PART A
DIRECTIONS
Poisons and hazardous substances required to be labelled with a warning statement
1. "AVOID CONTACT WITH THE SKIN AND EYES"
4. "FLAMMABLE"
5. "AVOID CONTACT WITH FOOD"
6. "WEAR PROTECTIVE GLOVES WHEN MIXING OR USING"
13. "(i) DO NOT USE IN FOOD CUPBOARDS:
(ii) DO NOT USE IN NURSERIES AND SICK-ROOMS WHERE PEOPLE MAY BE CONTINUOUSLY EXPOSED"
DO NOT ALLOW TO GET DAMP. STORE UNDER COVER IN A DRY, CLEAN, WELL VENTILATED PLACE DO NOT ALLOW TO COME IN CONTACT WITH ACIDS, REDUCING AGENTS, AMMONIUM COMPOUNDS, WOOD SHAVINGS, SAW DUST, PAPERS, FABRIC, PETROL, KEROSENE OR OTHER COMBUSTIBLE MATERIAL"
23. "MAY BE FATAL IF INHALED OR SWALLOWED"
25. "WEAR GOGGLES WHEN USING AS A FINE SPRAY"
"CAUTION - THIS PREPARATION IS FOR THE RELIEF OF MINOR AND TEMPORARY AILMENTS AND SHOULD BE USED STRICTLY AS DIRECTED. PROLONGED USE WITHOUT MEDICAL SUPERVISION COULD BE HARMFUL"
27. "FOR USE UNDER MEDICAL SUPERVISION ONLY"
34. "NOT FOR THERAPEUTIC USE"
PART B
Column 1
(Substance)
|
Column 2
(Directions)
(see1-36 above)
|
Acetic acid in concentrations of 80% or
more
|
3
|
Acifluorfen
|
1,25
|
Acrolein
|
2,4
|
Alkaline salts
|
22
|
Amidothion
|
2
|
Amines, aromatic, including phenylene
diamine, toluene diamine and other aromatic amines when used in hair
dyes
|
9
|
Aminocarb
|
2
|
2-Amino-5-diethylamino toluene
|
2
|
2-Amino-5-N-ethyl-N-B(hydroxy ethyl) amino
toluene
|
2
|
2-Amino-5-N-ethyl-N-B(methane sulphonamide
ethyl) amino toluene
|
2
|
2-Amino-5-N-ethyl-N-B(methoxyethyl) amino
toluene
|
2
|
Aniline
|
2
|
Antibiotic premixes for growth promotion
purposes
|
12
|
Antibiotic preparations for intramammary
treatment of animals
|
10
|
Antihistamine substances
|
17
|
Arsenic, organic compounds, when prepared for
use as herbicides or defoliants
|
2,5
|
Aspirin in sustained release preparations
containing 650 mg or more of aspirin
|
27
|
Aspirin, except in sustained release
preparations
|
26
|
Asthma sprays containing adrenaline, natural
or synthetic, its salts, noradrenaline and substances structurally derived
therefrom by substitution in the amine group, their salts
|
7
|
Azobenzene
|
2
|
Azocyclotin
|
2
|
Benomyl
|
33
|
Benzene
|
2,4,15
|
Benzoyl Peroxide, except when included in
Schedules 2, 3 or 4
|
1
|
Beryllium
|
2
|
BHC
|
2
|
Bithionol for the treatment of
animals
|
2
|
Bromophos
|
2
|
Bromophos-ethyl
|
2
|
2-Butoxy-2'-thiocyanodiethyl
ether
|
2
|
4-n-Butyl-4-H-1,2,4-triazole
|
2,6
|
Camphechlor
|
2
|
Captafol
|
19,25
|
Carbaryl, except when included in Schedule
2
|
2,21
|
Carbon disulphide
|
2,4
|
Carbon tetrachloride
|
15
|
Chlordane
|
2
|
Chlordimeform
|
2
|
Chlorfenethol
|
2
|
Chlorinating compounds and
bleaches
|
2
|
5-Chloro-3-methyl-4-nitropyrazole
|
2
|
alpha-(2-Chlorophenyl)-alpha-(4-chlorophenyl)-5-pyrimidinemethanol
|
1
|
Chloropicrin
|
2
|
Chlorpyrifos
|
2
|
Chlortetracycline in preparations for topical
application to animals for ocular use only
|
11
|
Chlorthiophos
|
1
|
Chromates and dichromates of alkali metals
and ammonium
|
2
|
Chromic acid
|
2
|
Crotoxyphos
|
2
|
Crufomate
|
2
|
Cyanoacrylic acid esters
|
2
|
Cyclohexanone peroxide
|
1
|
Cyhalothrin
|
2,6
|
Cypermethrin
|
1
|
DDT except for human therapeutic
use
|
2
|
Deltamethrin
|
2,6
|
Demeton-O-methyl
|
2
|
Demeton-S-methyl
|
2
|
Dialifos
|
2,21,24
|
Diazinon
|
2
|
Dibromochloropropane
|
2
|
Dichlofenthion
|
2
|
Dichloroethyl ether
|
2
|
Dichloroethylene
|
2,4
|
Dichloroisocyanurates
|
2
|
0-(2,4-Dichlorophenyl)-0-ethyl-S-propyl-phosphorodithioate
|
1
|
1-[2(2,4-Dichlorophenyl)-2-(2-propenyloxy)
ethyl]-1H-imidazole
|
1
|
N-3,4-Dichlorphenyl)-N'-[2-(sulfoxy-4'-chlorphenoxy)-5-chlorphenyl)urea
(sodium salt)
|
1
|
3,6-Dichloropicolinic acid
|
1
|
1,3-Dichloropropene
|
20
|
Dichlorvos except when included in Schedule
5
|
2
|
Dichlorvos when impregnated in plastic resin
strip material containing 20% or less dichlorvos
|
13
|
Dichlorvos when in aerosol packs containing
10 grammes or less of dichlorvos
|
21
|
N,N-Diethyl-p-phenylene diamine
|
2
|
Diethylene dioxide
|
2,4
|
2,3-Dihydro-5,6-dimethyl-1,4-dithiin-1,
1,4,4-tetraoxide
|
2
|
@imethanonaphthalene and all substitution
and/or addition products thereof
|
2
|
Dimethoate
|
2
|
1,3-Di
(methoxycarbonyl)-1-propen-2-yl-dimethyl phosphate
|
2
|
Dimethyl sulphoxide
(a) when not packed and labelled for
therapeutic use
(b) when packed and labelled for use in
animals
|
2,6,34
2,6,35
|
Dimetilan
|
2
|
Dinitrocresols and their homologues except
for therapeutic use
|
2
|
Dinitrophenols and their homologues except
for therapeutic use
|
2
|
DSMA
|
2,5
|
Econazole when included in Schedule 3 or 4 of
the Act
|
36
|
Endosulfan
|
2
|
Endothal
|
2
|
Epichlorohydrin
|
2
|
Epoxy resins liquid, and all amines and
organic anhydrides used as curing agents for epoxy resins
|
6
|
Ethephon
|
1
|
Ether solvent
|
2,4
|
Ethoate methyl
|
2
|
Ethofumesate
|
2
|
Ethyl bromide
|
2
|
Ethylene dibromide
|
2
|
Ethylene oxide
|
2,4
|
2'-Ethyl-N-(2-methoxy-1-methylethyl)-6'-methylchloroacetanilide
|
19,25
|
Famphur
|
2
|
Fenchlorphos
|
2
|
Fenitrothion
|
2
|
Fenthion
|
2
|
Flucythrinate
|
2,20,24
|
Formaldehyde
|
1
|
Formic acid
|
2
|
Formothion
|
2
|
Glazing preparations containing lead
compounds
|
16
|
Glyphosate
|
2
|
Guazatine
|
2,6
|
Halofuginone
|
2
|
Heptachlor
|
2
|
Hexachlorophane in preparations for skin
cleansing purposes containing 3% or less of hexachlorophane
|
14
|
Hydrazine
|
2
|
Hydrocarbons, liquid, distilling under
300°C
|
4
|
Hydrochloric acid
|
1
|
Hydrofluoric acid except when included in
Schedule 5
|
32
|
Hydrofluoric acid, hydrosilicofluoric acid,
their salts and other fluorine compounds when included in Schedule
5
|
1
|
Hydroquinone except when included in Schedule
4 of the Act
|
2
|
Hydrosilicofluoric acid except when included
in Schedule 5
|
32
|
8-Hydroxyquinoline, its derivatives and their
salts when prepared for internal use
|
8
|
Insecticidal preparations
|
5
|
Isocyanates, free organic
|
2
|
Isofenphos
|
1
|
Isopropyl-N-(3-N-ethyl-N-phenyl-carbamoyloxy)
phenylcarbamate
|
24
|
Kerosene
|
4
|
Lead components in hair
cosmetics
|
30
|
Lindane except when included in Schedule
2
|
2
|
Liquid epoxy resins and all amines and
organic anhydrides used as curing agents for epoxy resins
|
6
|
Maldison except when included in Schedule 2
of the Act
|
2,21
|
Menazon
|
2
|
Mepiquat
|
1
|
Metacresol sulphonic acid and formaldehyde
condensation product for animal use
|
1
|
Methamsodium
|
2
|
Methiocarb
|
2
|
Methyl alcohol
|
4
|
Methyl alcohol except in methylated
spirits
|
2
|
Methyl bromide
|
2
|
Methyl chloride
|
2
|
Methyl isothiocyanate
|
2
|
Methylated spirit
|
4
|
Methylene chloride
|
2
|
Methylene chloride in paint or lacquer
removers
|
15,29
|
Methylenebisthiocyanate
|
1
|
Methylethyl ketone peroxide
|
28
|
1-(B-Methyl sulphonamidoethyl)-2-amino-3-N,
N-diethylamino benzene
|
2
|
Mineral turpentine
|
4
|
Naled
|
2
|
Naphthalophos
|
2
|
Neomycin in preparations for topical
application to animals for ocular use only
|
11
|
Nicotine and its salts except in tobacco or
chewing tablets
|
2
|
Nimidane
|
2
|
Nitric acid
|
1
|
Nitrobenzene
|
2
|
2-n-Octyl-4-isothiazolin-3-one
|
2,6
|
Ofurace
|
1
|
Oil of turpentine
|
4
|
Omethoate
|
2
|
Organophosphorus and carbamate compounds for
pesticidal use except -
(a) di-allate, tri-allate, dazomet, mancozeb,
maneb, metiram, propineb, sulfallate, thiram, zineb and ziram; and
(b) impregnated plastic resins, strips or
granules and aerosol packs for household use
|
21
|
Oxalic acid and metallic
oxalates
|
1
|
Oxamyl
|
23,24*
|
Oxfendazole
|
1
|
Oxytetracycline in preparations for topical
application to animals for ocular use only
|
11
|
Oxythioquinox
|
1
|
Paracetamol
|
26
|
Pentachlorophenol
|
26
|
Peracetic acid
|
2
|
Petrol
|
4
|
Phenkapton
|
2
|
Phenol and any homologue of phenol boiling
below 220°
|
1
|
Phenols
|
6
|
ortho-Phenylphenol
|
1
|
Phosalone
|
2
|
Phosmet
|
2
|
Phosphides, metallic
|
2
|
Phosphonic acid
|
1
|
Phosphoric acid
|
1
|
Poly (hexamethylene biguanide)
hydrochloride
|
2
|
Potassium hydroxide
|
3
|
Potassium sulphide
|
3
|
Promecarb
|
2
|
Propachlor
|
2
|
Propetamphos
|
2
|
Propoxur except when included in Schedule 2
of the Act
|
2
|
Salicylamide
|
26
|
Salsalate
|
27
|
Selenium, compounds of, in preparations other
than for human therapeutic use
|
2
|
Sethoxydim
|
1
|
Sodium chlorate
|
1
|
Sodium fluoride in preparations for human
ingestion containing 2.2 mg or less of sodium fluoride per dosage
unit
|
31
|
Sodium hydroxide
|
3
|
Sodium sulphide
|
3
|
*Wear a respirator in place of a face shield.
Styrene
|
2
|
Sulphaquinoxaline when packed and labelled
for use as a coccidiostat in poultry except preparations containing 200 mg/kg or
less of sulphaquinoxaline
|
11
|
Sulphuric acid
|
1
|
TDE
|
2
|
Temephos
|
2
|
Terbuthylazine
|
2,6
|
Terpenes, chlorinated
|
2
|
Testosterone propionate, testosterone
dipropionate and testosterone enanthate in preparations for the treatment of
animals
|
11
|
Tetrachlorethane
|
15
|
Tetrachloroethylene except for therapeutic
use
|
2
|
Tetracycline in preparations for topical
application to animals for ocular use only
|
11
|
Tetradifon
|
2
|
Thidicarb
|
21
|
Thiobencarb
|
1,25
|
Thiometon
|
2
|
Toluene
|
2,4
|
S,S,S-Tributylphosphorothioate
|
2
|
Trichloroethylene except when specially
prepared for medical purposes
|
2
|
Trichloroisocyanuric acid
|
18
|
Trichlorophenol
|
2
|
Trichlorphon
|
2
|
Tridemorph
|
2
|
Triethyl phosphate
|
2
|
Trifluoromethanesulphonic acid in
concentrations of more than 10%
|
32
|
Trifluoromethanesulphonic acid in
concentrations of not more than 10%
|
2
|
Vamidothion
|
2
|
White spirit
|
4
|
Xylene
|
2,4
|
Zinc chloride
|
1
|
____________________________
SCHEDULE 6
Regulation 9(1)(f)
PART A
FIRST AID INSTRUCTIONS
(standard statements)
(a) If poisoning occurs, contact a doctor or Poisons Information Centre.
(b) If swallowed, induce vomiting. Use Ipecac Syrup (APF) if available.
(c) If swallowed, DO NOT induce vomiting. Give a glass of water.
(d) Avoid giving milk or oils.
(e) Avoid giving alcohol.
(f) If skin contact occurs, remove contaminated clothing and wash skin thoroughly.
(g) Remove from contaminated area. Apply artificial respiration if not breathing.
(h) If swallowed, induce vomiting. Use Ipecac Syrup (APF) if available. Give one Atropine tablet every quarter hour until dryness of the mouth occurs.
If poisoned by skin absorption, remove contaminated clothing and wash skin thoroughly. Give Atropine tablets as directed.
(i) If poisoning occurs get to a doctor or hospital quickly. If swallowed induce vomiting. Use Ipecac Syrup (APF) if available.
(j) If swallowed, give 1-3 cups of olive or other cooking oil or milk. Get to a doctor or hospital quickly.
(Cresols or Phenols 25% or less) if spilt on skin, wash thoroughly with soap and water, then methylated spirit.
(Cresols or Phenols in excess of 25%) if spilt on skin, swab repeatedly with glycerine, PEG (polyethylene glycol) or PEG - methylated spirit mixture or if necessary methylated spirit alone.
(k) If breathing, crush one amyl nitrite ampoule in handkerchief and hold under patient's nose for 1 or 2 seconds. Repeat up to 5 times at intervals of one minute.
If not breathing, wipe patient's lips and apply artificial respiration.
(l) Give activated charcoal and keep patient quiet, in a dark place if possible.
(m) If accidentally sucked, give milk or water, contact a doctor or Poisons Information Centre.
(n) If sprayed on skin, wash thoroughly. If sprayed in mouth, give milk or water.
(p) If swallowed do not induce vomiting give water or milk, then raw egg.
(q) If in eyes, hold eyes open, flood with water for at least 15 minutes and see a doctor.
PART B
GUIDE
(a) Where the First-Aid Instruction for a poison and its solvent are in conflict, the First-Aid Instruction for the poison is to prevail if its concentration expressed in grams per litre or grams per kilogram of preparation, is greater than the T value (i.e. toxicity) listed beside the substance specified below. If the concentration is equal to or less than the T value, then the instruction for the solvent is to prevail, provided that in the case of First-Aid instruction (h), the statements on skin absorption are to be retained.
(b) Where 2 or more substances specified below are present at concentrations less than their T-value and their First-Aid Instructions are in conflict with the solvent, calculate for each poison, the proportion of its T-value which its actual concentration C represents, (i.e. the C/T fraction) and add these fractions. If the total exceeds 1, the first aid for the substances is to prevail.
Note: that where the solvent concentration is low enough to result in exemption of the solvent from scheduling, for example at 25% for liquid hydrocarbons, then no conflict arises and the first aid for the poison automatically prevails.
2. Modified First-Aid Instruction for Dilute Preparations
Where the concentration of any substance specified below, expressed in grams per litre or grams per kilogram, is less than one tenth of the T-value listed beside that substance, then only First-Aid Instruction (a) need be written.
PART C
Column 1
(Substance)
|
Column 2
(First Aid Instructions)
(standard statements) - (a) to (q) above
|
T = Toxic value
|
Acephate
|
a,h
|
T = 90
|
Acetic acid
|
a,c,f,q
|
|
Acetic anhydride
|
a,c,f,q
|
|
Acetone as such or in preparations of equal
or lower viscosity
|
a,c
|
|
Acetone in other preparations
|
a,b
|
|
Acifluorfen
|
a,f
|
T = 100
|
Acrolein
|
a,b,f,g,q
|
T = 2
|
Aklomide
|
a,b
|
|
Alachlor
|
a,b
|
T = 120
|
Aldicarb
|
a,h
|
T = 0.1
|
Aldrin
|
a,b,d,f
|
T = 6
|
Alkaline Salts
|
a,c,q
|
|
Allidochlor
|
a,b
|
T = 70
|
Alloxydim
|
a
|
T = 220
|
Allyl alcohol
|
a,b,f,q
|
T = 6
|
Alpha-chloralose
|
a,b,e
|
T = 40
|
Ametryn
|
a,b
|
T = 140
|
Amidithion
|
a,h
|
T = 60
|
Amines and organic anydrides used as curing
agents for expoxy resins
|
a,c,f
|
|
2-Aminobutane
|
a,b
|
T = 30
|
Aminocarb
|
a,h
|
T = 5
|
4-Aminopyridine
|
a,b,f
|
T = 4
|
Amiton
|
a,h
|
T = 0.9
|
Amitraz
|
a,b
|
T = 30
|
Amitrole
|
a,b
|
T = 110
|
Ammonia 5% or less
|
a
|
|
Ammonia in excess of 5%
|
a,c,f,g
|
|
Ammonium bifluoride
|
a,c,f,q
|
|
Ammonium thiocyanate
|
a,b
|
T = 33
|
Aniline
|
a,b,f,g
|
T = 40
|
Anticoagulants
|
a,b
|
|
Antimony chloride
|
a,b,q
|
|
Antimony compounds
|
a,b
|
|
ANTU
|
a,b
|
T = 1
|
Arecoline
|
a,b
|
|
Arprinocid
|
a,b
|
T = 10
|
Arsenic compounds
|
a,b
|
|
Arsenic trioxide
|
a,b,q
|
|
Azamethiphos
|
a,b
|
T = 250
|
Azinphos-ethyl
|
a,h
|
T = 1
|
Azinphos-methyl
|
a,h
|
T = 1
|
Azobenzene
|
a,b
|
T = 100
|
Azocyclotin
|
a,b
|
T = 7
|
Barban
|
a,b
|
T = 130
|
Barium compounds, except for barium
sulphate
|
a,b
|
|
Bendiocarb
|
a,h
|
T = 3
|
Bendiocarb in aerosol packs
|
n
|
|
Benquinox
|
a,b
|
T = 10
|
Bensulide
|
a,h
|
T = 60
|
Bentazone
|
a,b
|
T = 110
|
Benzene
|
a,c,f,g
|
T = 160
|
Benzoyl peroxide
|
a,b,f,q
|
T = 10
|
Benthiocarb
|
a
|
T = 90
|
5-Benzylfur-3-ylmethyl (11R, 31S, E)-21,
21-dimethyl-31-
(2-oxo-2,3,4,5-tetrahydro-3-thienylidenemethyl)-cyclopropane
carboxylate
|
a,b
|
T = 200
|
BHC (see Lindane)
|
a,b,d,f
|
T = 8
|
BHC (except gamma isomer)
|
a,b,d,f
|
T = 50
|
Binapacryl
|
a,b,f,q
|
T = 30
|
Bleaches containing more than 4% available
chlorine
|
a,c,f
|
|
Borax
|
a,b
|
T = 100
|
Boric acid
|
a,b
|
T = 100
|
Boron compounds
|
a,b
|
|
Boron trifluoride
|
a,c,f,q
|
|
Bromadiolone in prepared baits
in concentrates
|
a
a,b
|
|
3-[3-(4'-Bromodiphenyl-4-yl)-
1,2,3,4-tetrahydronaphthyl]-4-
hydroxycoumarin in prepared
baits
in concentrates
|
a
a,b
|
|
Bromoform
|
a,b,f,g,q
|
|
Bromophos
|
a,h
|
T = 290
|
Bromophos-ethyl
|
a,h
|
T = 10
|
Bromoxynil
|
a,b
|
T = 10
|
Brotianide
|
a,b
|
T = 500
|
Brucine
|
a,l
|
T = 0.1
|
Butacarb
|
a,h
|
T = 150
|
Buthidazole
|
a
|
T = 120
|
2-Butoxy-2'-thiocyano diethyl
ether
|
a,b,f,q
|
T = 9
|
2-sec-Butylamino-4-ethylamino-6-methoxy
1,3,5-triazine
|
a,b
|
T = 260
|
2-tert-Butylamino-4-ethylamino-6-methoxy
1,3,5-triazine
|
a,b
|
T = 140
|
Butynorate
|
a
|
T = 20
|
Cadmium compounds
|
a,b
|
|
Calcium hypochlorite
|
a,c,f
|
|
Camphechlor
|
a,b,d,f
|
T = 8
|
Camphor
|
a,b,d
|
T = 0.5
|
Camphorated oil
|
a,b
|
T = 0.5
|
Captafol
|
a
|
|
Carbaryl
|
a,h
|
T = 50
|
Carbaryl in plastic resin strips
|
m
|
|
Carbofuran
|
a,h
|
T = 0.8
|
Carbon bisulphide
|
a,b,e,f,g,q
|
|
Carbon tetrachloride
|
a,b,e,f,g,q
|
T = 0.7
|
Carbophenothion
|
a,h
|
T = 3
|
Chlordane
|
a,b,d,f
|
T = 40
|
Chlordane in aerosol packs
|
n
|
|
Chlordecone
|
a,b,d,f
|
T = 10
|
Chlordimeform
|
a,b
|
T = 30
|
Chlorfenac
|
a,b
|
T = 170
|
Chlorfenethol
|
a,b
|
T = 90
|
Chlorfenson
|
a
|
T = 200
|
Chlorfenvinphos
|
a,h
|
T = 1
|
Chlorine gas
|
a,g,q
|
|
Chlormequat
|
a,b,q
|
T = 60
|
Chlornidine
|
a,b
|
T = 220
|
N-[5-Chloro-4-[(4-chlorophenyl)-cyanomethyl]-2-methylphenyl]-2-hydroxy-3,5-diiodobenzamide
- in concentrations not less than 5%
in concentrations less than 5%
|
a,b
a
|
T = 30
|
Chlorocresol
|
a,b,f,q
|
|
Chloroform
|
a,b,f,g,q
|
T = 80
|
Chloromethiuron
|
a
|
|
2-Chloro-N-[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)
aminocarbony l) benzene sulfonamide
|
a
|
T = 50
|
Chlorophacinone
|
a,b
|
T = 2
|
(beta-(4-Chlorophenoxy)-alpha-(1,1-dimethylethyl)1H-1,2,4-triazole-1-ethanol)
(triadimenol))
|
a
|
T = 110
|
Chloropicrin
|
a,f,g,q
|
T = 20
|
Chloropropylate
|
a
|
T = 500
|
Chlorothalonil
|
a
|
T = 1000
|
Chlorpyrifos
|
a,h
|
T = 13
|
Chlorpyrifos in aerosol packs
|
n
|
|
Chlorpyrifos-methyl
|
a,b
|
T = 160
|
Chlorthiamide
|
a,b
|
T = 70
|
Chlorthiophos
|
a,h
|
T = 0.4
|
Chromates
|
a,b,f,q
|
|
Chromium trioxide
|
a,c,f,q
|
|
Copper salts
|
a,b,f,q
|
|
Coumaphos
|
a,h
|
T = 1
|
Coumarin derivatives
|
a,b
|
|
Coumatetralyl
|
a
|
T = 1
|
4-CPA
|
a,b
|
T = 80
|
Creosote
|
a,f,j,q
|
T = 70
|
Cresols
|
a,f,j,q
|
|
Cresols in aerosol packs
|
n
|
|
Croton Oil
|
q
|
|
Crotoxyphos
|
a,h
|
T = 2
|
Crufomate
|
a,b
|
T = 7
|
Cyanatryn
|
a,b
|
T = 50
|
Cyanazine
|
a,b
|
T = 10
|
Cyanides
|
a,k
|
|
Cyanoacrylic acid esters
|
a
|
|
Cyclohexanone peroxide
|
a,f,q
|
|
Cyhalothrin
|
a,b
|
T = 7
|
Cyhexatin
|
a,b
|
T = 50
|
3-Cyclohexyl-6-(dimethylamino)-1-methyl-1,3,5-triazine-2,4-(1H,3H)-dione
|
a,b
|
T = 160
|
Cyclovoltyne
|
|
T = 180
|
Cypermethrin
|
a,b
|
T = 20
|
Cythioate
|
a,b
|
|
2,4-D
|
a,b
|
T = 30
|
Dazomet
|
a,b
|
T = 50
|
2,4-DB
|
a,b
|
T = 70
|
DDT
|
a,b,d,f
|
T = 10
|
Deltamethrin
|
a,b
|
T = 6
|
Demeton
|
a,h
|
T = 0.2
|
Demeton-O-methyl
|
a,h
|
|
Demeton-S-methyl
|
a,h
|
T = 6
|
2,4-DES
|
a,b
|
T = 70
|
Dialifos
|
a.h
|
T = 5
|
Di-allate
|
a,b,e
|
T = 30
|
N,N-Diallyldichloroacetamide
|
a
|
T = 170
|
Diazinon
|
a,h
|
T = 20
|
Diazinon in plastic resin strips
|
m
|
|
1,2-Dibromo-3-chloropropane
|
a,b
|
T = 17
|
Dicamba
|
a,b
|
T = 290
|
Dichlofenthion
|
a,h
|
T = 20
|
Dichlone
|
a,b
|
T = 130
|
Dichlofluanid
|
a,b
|
T = 30
|
o-Dichlorobenzene
|
a,b,e,f,q
|
|
p-Dichlorobenzene
|
a,b,d
|
T = 50
|
Dichloroethylene
|
a,b
|
T = 70
|
Dichloroethyl ether
|
a,f,g,q
|
T = 7
|
1-[2-(2,4-Dichlorophenyl)-4-propyl-1,3-dioxalan-2-yl-methyl]-1H--1,2,4-triazole
|
a
|
T = 130
|
1-[[2-(2,4-dichlorophenyl)-4
ethyl-1,3-dioxolan-2-yl] methyl]-1H-1,2,4-triazole
|
a,b
|
T = 130
|
1-[2(2,4-Dichlorophenyl)
-2-(2-propenyloxy)-1H-imidazole
|
a
|
T = 30
|
3,6-Dichloropicolinic acid
|
a
|
T = 280
|
N-(3,4-Dichlorphenyl)-N'-[2,-(2'-sulfoxy-4-'-chlorphenoxy)-5-chlorphenyl]-urea
(sodium salt)
|
a
|
T = 60
|
1,2-Dichloropropane
|
a,b,f,g,q
|
T = 14
|
1,3-Dichloropropene
|
a,b,f,g,q
|
T = 40
|
Dichlorvos
|
a,h
|
T = 5
|
Dichlorvos in aerosol packs
|
n
|
|
Dichlorvos in plastic resin
strips
|
m
|
|
Dichlorvos when in sustained release resin
pellets for veterinary use
|
a
|
|
Dichromates
|
a,b,f
|
|
Diclofop-methyl
|
a,b
|
T = 50
|
Dicloran
|
a,b
|
T = 150
|
Dicofol
|
a,b
|
T = 70
|
Dicrotophos
|
a,h
|
T = 2
|
Dieldrin
|
a,b,d,f
|
T = 4
|
Diethylene dioxide (Dioxane)
|
a,f,g
|
T = 710
|
Difenzoquat
|
a,b
|
T = 40
|
2,3,-Dihydro-5,6-dimethyl-1,4-dithiin-1,1,4,4,-tetraoxide
|
a,p
|
T = 110
|
Dimefox
|
a,h
|
T = 0.1
|
Dimethirimol
|
a,b
|
T = 230
|
Dimethoate
|
a,h
|
T = 30
|
1,3-Di(methoxycarbonyl)-1-propen-2-yl-dimethylphosphate
|
a,h
|
T = 3
|
Dimethylformamide -
less than 75%
75% or more
|
a,b
a,b,f,g,q
|
|
2-(2',4'-Dimethylphenylimino)-3-methyl-4-thiazoline
|
a,b,f
|
T = 70
|
Dimethyl sulphoxide
|
a,f
|
T = 2000
|
Dimetilan
|
a,h
|
T = 4
|
Dimetridazole
|
a,b
|
T = 160
|
Dinitramine
|
a,b
|
T = 300
|
Dinitrocresols
|
a,b,f,q
|
|
Dinitrophenols
|
a,b,f,q
|
|
Dinocap
|
a,b
|
T = 90
|
Dinoseb
|
a,b,e,f
|
T = 5
|
Dioxacarb
|
a,h
|
T = 7
|
Dioxathion
|
a.h
|
T = 2
|
Diphacinone
|
a,b
|
T = 0.3
|
Diphenamid
|
a,b
|
T = 90
|
Diquat
|
a,b,q
|
T = 10
|
Distillate
|
a,c
|
|
Disulfiram
|
a,b,e
|
T = 860
|
Disulfoton
|
a,h
|
T = 0.2
|
Dithianon
|
a,b
|
T = 50
|
Dithiocarbamates
|
a,e
|
|
3,3'-Di-(trifluoromethyl)-4-,4'-dichloro-N,N'-diphenyl
urea
|
a
|
|
Diuredosan
|
a,b
|
T = 10
|
DNOC
|
a,b,e,f,q
|
T = 2
|
Dodine
|
a,b
|
T = 100
|
2,2-DPA
|
a,b
|
T = 750
|
Endosulfan
|
a,b,d,f
|
T = 8
|
Endothal
|
a,b,f,q
|
T = 5
|
Endrin
|
a,b,d,f
|
T = 0.7
|
Epichlorohydrin
|
a,b,f,q
|
T = 9
|
Epoxy resins liquid
|
a,c,f,q
|
|
EPTC
|
a,b
|
T = 160
|
Ethephon
|
a,c
|
T = 420
|
Ether
|
a,b,g
|
T = 170
|
Ethiofencarb
|
a,h
|
T = 40
|
Ethion
|
a,h
|
T = 10
|
Ethoate-methyl
|
a,h
|
T = 30
|
Ethofumesate
|
a,c,f,q
|
T = 120
|
Ethoprophos
|
a,h
|
T = 6
|
Ethoxyquin
|
a,b
|
T = 80
|
Ethyl bromide
|
a,g
|
|
Ethyl formate
|
a,b,f,g,q
|
T = 180
|
Ethylene chlorohydrin
|
a,b,f,g,q
|
T = 9
|
Ethylene dibromide
|
a,b,f,g,q
|
T = 10
|
Ethylene dichloride
|
a,b,f,g,q
|
T = 70
|
Ethylene glycol
|
a,b
|
T = 30
|
Ethylene oxide
|
a,g,q
|
|
Etridiazole
|
a,b
|
T = 200
|
Eucalyptus oil
|
a,b
|
|
Famphur
|
a,h
|
T = 3
|
Fenaminosulf
|
a,b
|
T = 6
|
Fenamiphos
|
a,h
|
T = 1
|
Fenarimol
|
a
|
|
Fenazaflor
|
a,b
|
T = 10
|
Fenbutatin oxide
|
a,b
|
T = 260
|
Fenchlorphos
|
a,b
|
T = 170
|
Fenitrothion
|
a,h
|
T = 20
|
Fenoprop
|
a,b
|
T = 60
|
Fenson
|
a,b
|
T = 150
|
Fensulfothion
|
a,h
|
T = 0.2
|
Fenthion
|
a,h
|
T = 10
|
Fenthion-ethyl
|
a,h
|
|
Fenvalerate
|
a
|
T = 40
|
Ferbam
|
a
|
T = 400
|
Ferricyanides
|
a
|
|
Ferrocyanides
|
a
|
|
Fluazifop-butyl
|
a,b
|
T = 160
|
Fluchloralin
|
a,b
|
T = 150
|
Fluoracetamide
|
a,b
|
T = 1
|
Fluorides
|
a,b,q
|
|
Fluoroacetic acid
|
a,b,q
|
T = 1
|
Formaldehyde not less than 10%
|
a,b,f,g,q
|
|
Formaldehyde less than 10%
|
a,b
|
|
Formetanate
|
a,h
|
T = 2
|
Formic acid
|
a,c,f,q
|
|
Formothion
|
a,h
|
T = 30
|
Fospirate
|
a,h
|
T = 70
|
Furalaxyl
|
a,b
|
T = 90
|
Glutaraldehyde not less than 10%
|
a,p,q
|
|
Glutaraldehyde less than 10%
|
a,p
|
|
Glyphosate
|
a,c,f,q
|
T = 430
|
Guazatine
|
a,b
|
T = 20
|
Halofuginone
|
a,b,f,q
|
T = 0.3
|
HCB
|
a,b
|
|
Heptachlor
|
a,b,d,f
|
T = 10
|
Hydrazine
|
a,b,f,g,q
|
T = 70
|
Hydrocarbons, liquid
|
a,c
|
|
Hydrochloric acid
|
a,c,f,q
|
|
Hydrofluoric acid/ Hydrosilicofluoric acid
when included in Schedule 5
when included in Schedule 6
|
a,
a,c,f
|
|
Hydrogen peroxide
|
a,c,f
|
|
Hydroquinone
|
a,b,q
|
T = 30
|
Imidocarb dipropionate
|
a
|
T = 60
|
Iodine
|
a,b,f,q
|
T = 10
|
Iodofenphos
|
a,b
|
T = 210
|
Iodofenphos in plastic resin
strips
|
m
|
|
Iodophors in excess of 10%
10% or less
|
a,b
a
|
|
Ioxynil
|
a,b
|
T = 10
|
Iron compounds in solid and liquid
preparations for animal treatment
|
a,b
|
|
2-Isobutylamino-4-ethylamino-6-methoxy-1,3,5-triazine
|
a,b
|
|
Isocarbophos
|
a,h
|
T = 2
|
Isocyanates, free organic
|
a,f
|
|
Isofenphos
|
a,h
|
T = 2
|
Kerosene
|
a,c
|
|
Lactic acid
|
q
|
|
Lauryl isoquinolinium bromide
|
a,b
|
|
Lead arsenate
|
a,b
|
T = 40
|
Lead compounds
|
a,b,f
|
|
Leptophos
|
a,h
|
T = 4
|
Lindane not less than 2%
|
a,b,d,f,q
|
T = 8
|
Lindane less than 2%
|
q
|
T = 8
|
Maldison
|
a,b
|
T = 280
|
Mancozeb
|
a,e
|
T = 800
|
Maneb
|
a,e
|
T = 670
|
Mazidox
|
a,h
|
|
MCPA
|
a,b
|
T = 70
|
MCPB
|
a,b
|
T = 60
|
Mecarbam
|
a,h
|
T = 3
|
Mecoprop
|
a,b
|
T = 90
|
Menazon
|
a,b
|
T = 80
|
Mepiquat
|
a
|
T = 140
|
*Mercuric chloride
|
a,b,f
|
T = 0.1
|
*Mercuric iodide
|
a,b
|
T = 4
|
*Mercuric thiocyanate
|
a,b
|
|
*Mercurous chloride
|
a,b
|
T = 20
|
*Mercury, organic compounds
|
a,b,f
|
|
Metacresolsulphonic acid and formaldehyde
condensation product
|
a,c
|
|
Metaldehyde
|
a,b
|
T = 60
|
Metaldehyde in pressurized
sprays
|
a,n
|
|
Metaxanine
|
a,b
|
T = 60
|
Methabenzthiazuron
|
a,b
|
T = 100
|
Metham
|
a,b,e,f
|
T = 80
|
Methamidophos
|
a,h
|
T = 3
|
Methazole
|
a,b,f,q
|
T = 100
|
Methidathion
|
a,h
|
T = 2
|
Methiocarb
|
a,h
|
T = 10
|
Methomyl
|
a,h
|
T = 1
|
0-2-Methoxycarbonylprop-1-enyl-0,0-dimethylphosphorothioate
|
a,h
|
T = 30
|
Methoxychlor
|
a,b
|
T = 250
|
Methyl alcohol
|
a,b,q
|
T = 650
|
Methylated spirit
|
a,b
|
|
Methyl bromide
|
a,f,g
|
|
N-Methyl carbamates
|
a,h
|
|
Methyl chloride
|
a,g
|
|
Methylene bisthiocyanate
|
a,b
|
T = 5
|
Methylene chloride
|
d
|
T = 160
|
Methylene chloride in aerosol
packs
|
n
|
|
Methylethyl ketone as such, or in
preparations of equal or lower viscosity
|
a,c
|
|
Methylethyl ketone in other
preparations
|
a,b
|
|
Methylethyl ketone peroxide
|
a,c,f
|
T = 40
|
Methylisoamyl ketone as such, or in
preparations of equal or lower viscosity
|
a,c
|
|
* If swallowed, give raw egg whites if
available, then induce vomiting.
Use Ipecac Syrup (APF) if
available.
|
|
|
Methylisoamyl ketone in other
preparations
|
a,b
|
|
Methylisobutyl ketone as such, or in
preparations of equal or lower viscosity
|
a,c
|
|
Methylisobutyl ketone in other
preparations
|
a,b
|
|
Methyl isothiocyanate
|
a,b,f,q
|
T = 10
|
3-(Methylsulfonyl)butanon-0-methylcarbamoyloxim:
when included in Schedule 5 of the
Act
when included in Schedule 6 of the
Act
|
a
a,b
|
T = 40
|
Metiram
|
a,e
|
T = 680
|
Metolachlor
|
a
|
T = 270
|
Metribuzin
|
a,b
|
T = 115
|
Mevinphos
|
a,h
|
T = 0.3
|
Mezineb
|
a,e
|
T = 850
|
Mineral turpentine
|
a,c
|
|
Mipafox
|
a,h
|
T = 8
|
Mirex
|
a,b,d,f
|
|
Molinate
|
a,b
|
T = 70
|
Monocrotophos
|
a,h
|
T = 0.8
|
NAA
|
a,f,q
|
T = 100
|
Nabam
|
a,b,d,e
|
T = 30
|
Naled
|
a,h
|
T = 40
|
Naled in plastic strips
|
m
|
|
Naphthalene
|
a,b
|
T = 220
|
Naphthalophos
|
a,h
|
T = 7
|
Narasin
|
a,b,q
|
|
Nicotine
|
a,b,q
|
T = 5
|
Nitralin
|
a,b
|
T = 470
|
Nitric acid
|
a,c,f,q
|
|
Nitrobenzene
|
a,b,f
|
T = 30
|
Nitrophenol
|
a,b,f
|
T = 90
|
Nitroxynil
|
a,b
|
|
Norbormide
|
a,b
|
T = 10
|
2-n-Octyl-4-isothiazolin-3-one
|
a,b,f
|
|
Ofurace
|
a
|
T = 250
|
Olaquindox
|
a,b
|
T = 170
|
Omethoate
in 0.2% aerosols
|
a,h
n
|
|
Organophosphorus compounds not elsewhere
specified in this Schedule
|
a,h
|
|
Oxadiazon
|
a
|
T = 125
|
Oxalic acid
|
a,c,f
|
T = 50
|
Oxamyl
|
a,h
|
T = 0.5
|
Oxfendazole
|
a,b
|
T = 1000
|
Oxycarboxin
|
a,b
|
T = 250
|
Oxyflurorfen
|
a,q
|
|
Oxythioquinox
|
a,b
|
T = 250
|
Paraquat
|
i,q
|
|
Parathion
|
a,h,q
|
T = 0.3
|
Parathionmethyl
|
a,h
|
T = 1
|
Pebulate
|
a,b
|
T = 110
|
Pendimethalin
|
a,b
|
|
Pentachlorophenol
|
a,b,d,f
|
T = 20
|
Peracetic Acid
|
a,c,f
|
|
Perfluidone
|
a,b
|
T = 50
|
Permanganates
|
a,c,f
|
|
Petrol
|
a,c,g
|
|
Phenkapton
|
a,g
|
T = 6
|
Phenols
|
a,j
|
|
Phenols in aerosol packs
|
n
|
|
Phenylene diamines
|
a,b,f
|
|
ortho-Phenylphenol
|
a,b,f
|
T = 240
|
ortho-Phenylophenol in aerosol
packs
|
n
|
|
Phorate
|
a,h
|
T = 0.1
|
Phosalone
|
a,h
|
T = 10
|
Phosfolan
|
a,h
|
T = 0.8
|
Phosmet
|
a,h
|
T = 20
|
Phosphamidon
|
a,h
|
T = 2
|
Phosphides, metallic
|
a,g
|
|
Phosphonic acid
|
a,c,f
|
|
Phosphonic acid in spray packs
|
a,n,q
|
|
Phosphoric acid
|
a,c,f
|
|
Phosphorus, yellow
|
a,b,f
|
T = 0.01
|
Phoxim
|
a,h
|
T = 90
|
Picric acid
|
a,b,f,g
|
T = 0.3
|
Pindone
|
a
|
T = 20
|
Piperophos
|
a,h
|
T = 10
|
Pirimicarb in concentrations greater than 5
g/L
- in concentrations containing 5 g/L or
less
- in aerosols containing 5 g/L or less of
pirimicarb
|
a,h
a,b
n
|
T = 10
|
Pirimiphos-ethyl
|
a,b
|
T = 14
|
Pirimiphos-methyl
|
a,h
|
T = 110
|
Poly (hexamethylene biguanide)
hydrochloride
|
a,b
|
T = 100
|
Potassium bromate
|
a,b
|
|
Potassium cyanate
|
a,b
|
|
Potassium hydroxide
|
a,c,f
|
|
Profenofos
|
a,h
|
T = 30
|
Promacyl
|
a,b
|
T = 120
|
Promecarb
|
a,h
|
T = 3
|
Prometryn
|
a,b
|
T = 310
|
Propachlor
|
a,b
|
T = 200
|
Pyrethrins
|
a,b
|
|
Propanil
|
a,b
|
T = 50
|
Propargite
|
a,b
|
T = 220
|
Propetamphos
|
a,h
|
T = 4
|
Propionic acid
|
a,b
|
T = 260
|
Propoxur
|
a,h
|
T = 9
|
Propoxur in plastic resin strips
|
m
|
|
Prothiophos
|
a,h
|
T = 90
|
Prynachlor
|
a,b
|
T = 110
|
Pyrazophos
|
a,h
|
T = 20
|
Pyrethrins in aerosol packs
|
n
|
|
N-3-Pyridylmethyl-N'-Pyrithione
Zinc
|
a,b
|
T = 30
|
p-nitrophenylurea
|
a,b
|
T = 1
|
Quarternary ammonium compounds in excess of
20%
20% or less
|
a,p
a
|
|
Quarternary ammonium compounds in aerosol
packs
|
n
|
T = 1200
|
Quintozene
|
a
|
|
Salicylanilide
|
a,b
|
|
Salinomycin in concentrations greater than 6%
w/w
- in concentrations of 6% w/w or
less
|
a,b
a
|
T = 5
|
Schradan
|
a,h
|
T = 0.9
|
Selenium compounds
|
a,b,d,f
|
|
Sethoxydim
|
a
|
T = 300
|
Sodium bifluoride
|
a,c,f
|
|
Sodium bromate
|
a,b
|
|
Sodium chlorate
|
a
|
T = 120
|
Sodium dichloroisocyanurate
|
a,c,f
|
T = 140
|
Sodium hydrogen sulphate
|
a,c,f
|
|
Sodium hydroxide
|
a,c,f
|
|
Sodium nitrite
|
a,b
|
T = 10
|
Sodium trichloroacetate
|
a,b
|
T = 320
|
Sodium trichloroisocyanurate
|
a,c,f
|
T = 70
|
Strychnine
|
a,l
|
T = 0.5
|
Styrene
|
a,c,f
|
T = 500
|
Sulfallate
|
a,b
|
T = 80
|
Sulfotep
|
a,h
|
|
Sulphuric acid
|
a,c,f,q
|
T = 10
|
Sulprophos
|
a,h
|
T = 0.5
|
2,4,5,-T
|
a,b
|
T = 20
|
2,3,6-TBA
|
a,b
|
T = 150
|
TCA (acid)
|
a,c,f,q
|
T = 40
|
TCA sodium salt
|
a,b
|
T = 320
|
TCMTB
|
a,b
|
T = 150
|
TDE
|
a,b
|
T = 340
|
Temephos
|
a,h
|
T = 130
|
TEPP
|
a,h
|
T = 0.1
|
Terbuthylazine
|
a,b
|
T = 210
|
Terbutryn
|
a,b
|
T = 240
|
Terpenes, chlorinated
|
a,b
|
|
Tetrachloroethane
|
a,b,e,f,g
|
T = 20
|
Tetrachloroethylene
|
a,b,d,e,f,g
|
|
Tetrachlorvinphos
|
a,b
|
T = 400
|
Tetradifon
|
a
|
|
Thallium
|
a,b
|
T = 3
|
Thiazafluron
|
a,b
|
T = 20
|
Thiodicarb
|
a,h
|
T = 3
|
Thiometon
|
a,h
|
T = 10
|
Thiourea
|
a,b
|
T = 0.1
|
Thiram
|
a,b,e
|
T = 30
|
Tin, organic compounds
|
a,b,f
|
|
Dimethyl tin dichloride
|
a,b,f
|
T = 7
|
Dibutyl tin salts
|
|
|
di (2-ethylhexoate)
|
a,b,f
|
T = 20
|
di (butyl maleate)
|
a,b,f
|
T = 12
|
di (nonyl maleate)
|
a,b,f
|
T = 17
|
dichloride
|
a,b,f
|
T = 10
|
S,S'-bis (2-ethyl-
hexylmercaptoacetate)
|
a,b,f
|
T = 15
|
dilaurate
|
a,b,f
|
T = 4
|
oxide
|
a,b,f
|
T = 50
|
sulphide
|
a,b,f
|
T = 10
|
Trimethyl tin chloride
|
a,b,f
|
T = 0.9
|
Trimethyl tin acetate
|
a,b,f
|
T = 0.4
|
Tripropyl tin acetate
|
a,b,f
|
T = 4
|
Tributyl tin salts acetate, benzoate,
chloride, oleate, salicylate
|
a,b,f
|
T = 10
|
oxide (bis)
|
a,b,f
|
T = 5
|
Triphenyl tin acetate
|
a,b,f
|
T = 6
|
chloride, hydroxide
|
a,b,f
|
T = 8
|
o-Tolidine
|
a,b
|
T = 40
|
Toluene in excess of 75%
75% or less
|
a,c,f,g
a,c
|
|
Toluene in aerosol packs
|
n
|
|
Triadimefon
|
a,b
|
T = 30
|
Tri-allate
|
a,b,e
|
T = 40
|
Triazbutil
|
a,b
|
T = 5
|
S,S,S-Tributylphosphorothiolate
|
a,h
|
T = 30
|
1,1,1-Trichloroethane
|
a,b
|
|
Trichloroethylene
|
a,b,d,e,f,g
|
T = 715
|
Trichloroisocyanuric acid
|
a,c,f
|
T = 70
|
Trichlorophenol
|
a,j
|
T = 80
|
Trichlorphon
|
a,h
|
T = 60
|
Tricliopyr (as triethylamine
salt)
|
a,b
|
T = 70
|
Tridemorph
|
a,b
|
T = 100
|
Trietazine
|
a,b
|
T = 50
|
Triethyl phosphate
|
a,b
|
|
Trifluoromethane sulphonic acid
|
a,p,q
|
|
Turpentine oil
|
a,b,q
|
T = 7
|
Vamidothion
|
a,h
|
T = 6
|
Vernolate
|
a,b
|
T = 170
|
Warfarin
|
a
|
T = 0.3
|
White spirit
|
a,c
|
|
Xylene in excess of 75%
75% or less
|
a,c,f,g
a,c
|
|
Xylene in aerosol packs
|
n
|
|
Xylenols
|
a,c,f,q
|
|
Xylenols in aerosol packs
|
n
|
|
Zinc chloride
|
a,c,q
|
T = 30
|
Zinc p-phenosulphonate
|
a,q
|
|
Zinc sulphate
|
a,q
|
|
Zineb
|
a,e
|
T = 520
|
Ziram
|
a,b,f,q
|
T = 140
|
____________________________
Notes
1. The Poisons and Dangerous Drugs Regulations, in force under the Poisons and Dangerous Drugs Act, comprise the Regulations 1985, No. 9 and amendments made by other legislation, the details of which are specified in the following table:
Year and number
|
Date made
|
Date notified in the
Gazette
|
Date of commencement
|
1985, No. 9
|
30 Apr 1985
|
15 May 1985
|
29 May 1985 (a)
|
Act No. 17, 1997
|
-
|
30 April 1997
|
s. 16: 10 Dec 1997; Remainder: 1 May
1997
|
Act No. 62, 2001
|
-
|
-
|
s. 6: 15 July 2001;
s. 8: 1 Jan 2001;
s. 9(2): 29 June 2001; Remainder: 11 Dec 2001 (b) |
(a) Regulation 2 provides as follows:
"These Regulations shall come into operation at the expiration of 14 days from the date on which the making of the Regulations is notified in the Gazette.".
(b) Section 2 of the Statute Law Revision Act (No. 2) 2001 provides as follows:
"2. Commencement
"(1) Section 6 is to be taken to have come into operation on the day on which, but immediately after, the Corporations Reform (Consequential Amendments NT) Act 2001 commenced.
"(2) Section 8 is to be taken to have come into operation on the day on which, but immediately before, the Firearms Amendment Act (No. 2) 2000 commenced.
"(3) Section 9(2) is to be taken to have come into operation on the day on which, but immediately after, the Gaming Machine Amendment Act (No. 2) 2001 commenced.
"(4) The remaining provisions of this Act come into operation on the day on which the Administrator's assent to this Act is declared.".
____________________________
Table of Amendments
Regulation
3. Amended by No. 17, 1997, s. 18
9. Amended by No. 17, 1997, s. 18
15. Amended by Act No. 62, 2001
____________________________
__________________